Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options (Tables)

v3.23.1
Stock-Based Compensation, Restricted Stock and Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Stock Options, Restricted Stock Units And Warrants [Abstract]  
Schedule of stock-based compensation
    Year Ended
December 31,
    Nine Months Ended December 31,  
    2022     2021  
             
Research and development expenses   $ 508     $ 384  
Selling, general and administrative expenses     1,897       8,318  
Total stock-based compensation   $ 2,405     $ 8,702  

 

Schedule of restricted stock activity
    Number of
Shares
    Weighted Average
Grant-Date
Fair Value
 
Unvested at December 31, 2021     1,939,683     $ 3.40  
Granted     676,350     $ 1.37  
Vested     (892,016 )   $ 2.09  
Issued     (1,095,237 )   $ 4.50  
Unvested at December 31, 2022     628,780     $ 2.30  

 

Schedule of fair value of stock options granted
    Year Ended
December 31,
  Nine Months Ended
December 31,
    2022   2021
Dividend yield   0%   0%
Expected price volatility  
88.8% - 91.7%
 
50% - 103%
Risk free interest rate  
3.96% - 3.25%
 
0.35% - 1.33%
Expected term  
 5.0 - 7.0 years
 
 3-7 years

 

Schedule of activity under the 2016 and 2020 plans
    Shares Underlying Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual
 Term (Years)
    Aggregate Intrinsic Value  
Outstanding at December 31, 2021     11,135,432     $ 2.85       7.6     $ 13,031  
Granted     832,500     $ 0.40      
-
         
Canceled     (977,638 )   $ 3.20      
-
         
Forfeited     (1,476,670 )   $ 2.60       -          
Outstanding at December 31, 2022     9,513,624     $ 2.64       6.5     $ 26,188  
                                 
Exercisable at December 31, 2022     8,579,370     $ 2.80       6.3     $ 26,188  

 

Schedule of warrant (excluding penny warrants) activity
    Shares
Underlying
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021     4,525,177     $ 2.65       4.0     $ 7,088  
Issued     23,136,004     $ 0.38                  

Outstanding and Exercisable at December 31, 2022

    27,661,181     $ 0.75       4.5     $
-
 

 

Schedule of fair value of equity classified warrants using the black-scholes pricing
    Year Ended
December 31,
2022
  Nine Months
Ended
December 31,
2021
Dividend yield   0%   0%
Expected price volatility   87.3%-103.0%   50%-103%
Risk free interest rate   2.2%-3.0%   0.81%-1.2%
Expected term (years)   5.0   5.0